Jacob P. Laubach, MD
Dana-Farber Cancer Institute
2
1
2
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yvonne A. Efebera, MD
Ohio State University Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Evanthia Galanis, MD
Alliance Foundation Trials, LLC.
Shared therapeutic areas:
Worked with same sponsors:
Ravi Vij, M.D.
Washington University School of Medicine
Shared therapeutic areas:
Worked with same sponsors:
David Avigan, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Worked with same sponsors:
PEGOURIE, MD
University Hospital, Grenoble
Shared therapeutic areas:
Michel ATTAL, MD, PhD
University Hospital, Toulouse
Shared therapeutic areas:
AUGEL MEUNIER, MD
CHU ST PRIEST EN JAREZ
Shared therapeutic areas:
MOREL, MD
Hôpital la Pitié Salpêtrière Paris
Shared therapeutic areas:
BENBRAHIM, MD
CH ORLEANS
Shared therapeutic areas:
Areej El-Jawahri, MD
Massachusetts General Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
All 2 trials loaded